Q-linea’s ASTar launched in Europe

Q-linea AB (publ) (OMX: QLINEA), a diagnostics company focusing on developing and delivering solutions for diagnosing infectious diseases accurately and quickly, today announces that the company’s commercial partner Thermo Fisher Scientific is officially launching ASTar for the European market.

“It is of course very satisfying to now see the official launch by Thermo Fisher Scientific ™ in Europe. ASTar has been tested by several hospitals during the summer with fantastic results and we are really looking forward to the coming year”, said Jonas Jarvius, CEO of Q-linea.

Please see the link for the press release in its entirety:
https://www.prnewswire.co.uk/news-releases/thermo-fisher-scientific-and-q-linea-launch-astar-system-a-rapid-antimicrobial-susceptibility-testing-system-835609700.html

About Q-linea

Q-linea is an innovative infection diagnostics company that primarily develops instruments and disposables for rapid and reliable infection diagnostics. Our vision is to help save lives by ensuring antibiotics continue to be an effective treatment for future generations. Q-linea develops and delivers preferred solutions for healthcare providers, enabling them to accurately diagnose and treat infectious disease in the shortest possible time. The company’s lead product ASTar® is a fully automated instrument for antibiotic susceptibility testing (AST), giving a susceptibility profile within six hours directly from a positive blood culture. For more information, please visit www.qlinea.com.

Q-linea's ASTar launched in Europe